GSK Investigational Site

Parramatta, New South Wales 2150

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections, Infection, Human Immunodeficiency Virus

Studies at this site

• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) — Completed